Geode Capital Management’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$94.5M Buy
1,934,593
+60,707
+3% +$2.97M 0.01% 1063
2025
Q1
$95.5M Buy
1,873,886
+76,870
+4% +$3.92M 0.01% 996
2024
Q4
$81.1M Sell
1,797,016
-1,650
-0.1% -$74.5K 0.01% 1126
2024
Q3
$66.7M Buy
1,798,666
+10,886
+0.6% +$404K 0.01% 1252
2024
Q2
$54.7M Buy
1,787,780
+124,712
+7% +$3.81M ﹤0.01% 1295
2024
Q1
$48.4M Buy
1,663,068
+51,843
+3% +$1.51M ﹤0.01% 1378
2023
Q4
$44.4M Buy
1,611,225
+89,396
+6% +$2.46M ﹤0.01% 1417
2023
Q3
$34.1M Buy
1,521,829
+62,289
+4% +$1.4M ﹤0.01% 1490
2023
Q2
$59.4M Buy
1,459,540
+74,130
+5% +$3.01M 0.01% 1123
2023
Q1
$67.1M Buy
1,385,410
+58,786
+4% +$2.85M 0.01% 987
2022
Q4
$50.6M Buy
1,326,624
+47,426
+4% +$1.81M 0.01% 1137
2022
Q3
$64.2M Sell
1,279,198
-54,321
-4% -$2.73M 0.01% 918
2022
Q2
$53.4M Buy
1,333,519
+42,380
+3% +$1.7M 0.01% 1067
2022
Q1
$48.2M Buy
1,291,139
+19,009
+1% +$709K 0.01% 1277
2021
Q4
$50.7M Sell
1,272,130
-6,496
-0.5% -$259K 0.01% 1305
2021
Q3
$47.6M Buy
1,278,626
+11,287
+0.9% +$420K 0.01% 1321
2021
Q2
$53.6M Buy
1,267,339
+118,239
+10% +$5M 0.01% 1248
2021
Q1
$54.4M Buy
1,149,100
+104,952
+10% +$4.97M 0.01% 1162
2020
Q4
$63.7M Buy
1,044,148
+64,473
+7% +$3.93M 0.01% 948
2020
Q3
$45.8M Buy
979,675
+18,444
+2% +$862K 0.01% 968
2020
Q2
$48.8M Buy
961,231
+33,785
+4% +$1.71M 0.01% 906
2020
Q1
$41.4M Buy
927,446
+67,097
+8% +$2.99M 0.01% 861
2019
Q4
$41.3M Buy
860,349
+73,080
+9% +$3.51M 0.01% 1062
2019
Q3
$26.6M Buy
787,269
+52,852
+7% +$1.79M 0.01% 1287
2019
Q2
$33M Buy
734,417
+53,069
+8% +$2.39M 0.01% 1136
2019
Q1
$25.6M Buy
681,348
+117,942
+21% +$4.44M 0.01% 1252
2018
Q4
$19.3M Buy
563,406
+37,593
+7% +$1.29M 0.01% 1305
2018
Q3
$24.7M Buy
525,813
+79,294
+18% +$3.73M 0.01% 1251
2018
Q2
$15.1M Buy
446,519
+81,197
+22% +$2.74M ﹤0.01% 1564
2018
Q1
$9.89M Buy
365,322
+50,210
+16% +$1.36M ﹤0.01% 1771
2017
Q4
$5.26M Sell
315,112
-47,893
-13% -$799K ﹤0.01% 2182
2017
Q3
$7.26M Buy
363,005
+71,590
+25% +$1.43M ﹤0.01% 1968
2017
Q2
$5.34M Buy
291,415
+21,151
+8% +$388K ﹤0.01% 2105
2017
Q1
$2.66M Buy
270,264
+10,958
+4% +$108K ﹤0.01% 2494
2016
Q4
$2.83M Buy
259,306
+30,111
+13% +$329K ﹤0.01% 2425
2016
Q3
$3.21M Buy
229,195
+3,442
+2% +$48.2K ﹤0.01% 2254
2016
Q2
$1.58M Buy
225,753
+1,700
+0.8% +$11.9K ﹤0.01% 2640
2016
Q1
$1.44K Buy
224,053
+5,167
+2% +$33 ﹤0.01% 2670
2015
Q4
$7.09M Buy
218,886
+4,743
+2% +$154K ﹤0.01% 1616
2015
Q3
$5.72M Buy
214,143
+55,661
+35% +$1.49M ﹤0.01% 1757
2015
Q2
$7.63M Buy
158,482
+13,379
+9% +$644K ﹤0.01% 1609
2015
Q1
$8.83M Sell
145,103
-985
-0.7% -$59.9K 0.01% 1477
2014
Q4
$7.56M Buy
146,088
+16,134
+12% +$835K ﹤0.01% 1554
2014
Q3
$5.72M Buy
129,954
+2,122
+2% +$93.4K ﹤0.01% 1679
2014
Q2
$3.34M Buy
127,832
+27,938
+28% +$730K ﹤0.01% 2051
2014
Q1
$2.61M Buy
99,894
+50,799
+103% +$1.33M ﹤0.01% 2180
2013
Q4
$833K Buy
49,095
+693
+1% +$11.8K ﹤0.01% 2829
2013
Q3
$1.04M Buy
+48,402
New +$1.04M ﹤0.01% 2567